• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名急性早幼粒细胞白血病患者的罕见t(3;15;17):病例报告及文献复习

A Rare t(3;15;17) in a Patient with Acute Promyelocytic Leukemia: Case Report and Review of the Literature.

作者信息

Shi Linda, Chen Chu En, Ahmed Tahmeena, Rocha Jacob, Materum Pons, Cherukuri Sashank, Gallagher Leah, Fernicola Paula, Ponce Roxana, Lee Htien, Giordano Christina, Evans Gabriela, Tian Changtai, Tirado Carlos A

机构信息

The International Circle of Genetics Studies Project, New York Chapter, 25 Pinnacle Dr., New York, NY 11777, USA.

Renaissance School of Medicine, Stony Brook University, Stony Brook, NY 11794, USA.

出版信息

Diagnostics (Basel). 2025 Jul 29;15(15):1901. doi: 10.3390/diagnostics15151901.

DOI:10.3390/diagnostics15151901
PMID:40804865
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12345950/
Abstract

We present a 48-year-old female with a past medical history of endometrioid adenocarcinoma who presented with symptoms of spontaneous gum bleeding, post-coital bleeding, and upper extremities-lower extremities-abdomen ecchymosis. Initial laboratory findings were significant for cytopenia and disseminated intravascular coagulation (DIC). Due to a suspected case of acute promyelocytic leukemia (APL), conventional karyotyping and fluorescence in situ hybridization (FISH) were performed. FISH analysis confirmed an unusual chromosome rearrangement that affected chromosomes 3, 15, and 17. This t(3;15;17)(q29;q24;q21) was characterized by the presence of fusion on the derivative chromosome 15. Treatment at the hospital with standard APL therapy of all-trans retinoic acid (ATRA) and arsenic trioxide (ATO) was complicated by the development of differentiation syndrome, which necessitated the temporary stoppage of ATO. However, complete remission was achieved despite complications after starting consolidation treatment.

摘要

我们报告一名48岁女性,既往有子宫内膜样腺癌病史,出现自发性牙龈出血、性交后出血以及上肢、下肢和腹部瘀斑症状。初始实验室检查结果显示血细胞减少和弥散性血管内凝血(DIC)。由于疑似急性早幼粒细胞白血病(APL),进行了传统核型分析和荧光原位杂交(FISH)。FISH分析证实了一种影响3号、15号和17号染色体的异常染色体重排。这种t(3;15;17)(q29;q24;q21)的特征是在衍生染色体15上存在融合。在医院接受全反式维甲酸(ATRA)和三氧化二砷(ATO)的标准APL治疗时,出现了分化综合征,这使得ATO不得不暂时停用。然而,尽管在开始巩固治疗后出现了并发症,但仍实现了完全缓解。

相似文献

1
A Rare t(3;15;17) in a Patient with Acute Promyelocytic Leukemia: Case Report and Review of the Literature.一名急性早幼粒细胞白血病患者的罕见t(3;15;17):病例报告及文献复习
Diagnostics (Basel). 2025 Jul 29;15(15):1901. doi: 10.3390/diagnostics15151901.
2
[Arsenic trioxide in combination with all-trans retinoic acid for acute promyelocytic leukemia: a systematic review and meta-analysis].三氧化二砷联合全反式维甲酸治疗急性早幼粒细胞白血病:一项系统评价与荟萃分析
Zhong Xi Yi Jie He Xue Bao. 2009 Nov;7(11):1024-34. doi: 10.3736/jcim20091102.
3
Long-term follow-up of a phase 2 study of all-trans retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin in acute promyelocytic leukemia.全反式维甲酸、三氧化二砷和吉妥单抗奥唑米星治疗急性早幼粒细胞白血病的2期研究长期随访
Cancer. 2025 Jan 1;131(1):e35662. doi: 10.1002/cncr.35662. Epub 2024 Nov 25.
4
[A case of acute promyelocytic leukemia with NUP98::RARG::LINE-L2a tripartite fusion and the mechanism of resistance to all-trans retinoic acid].一例伴有NUP98::RARG::LINE-L2a三方融合的急性早幼粒细胞白血病及对全反式维甲酸耐药的机制
Zhonghua Yi Xue Za Zhi. 2025 Jul 8;105(25):2120-2123. doi: 10.3760/cma.j.cn112137-20250226-00450.
5
Superiority of anthracycline-free treatment in standard-risk acute promyelocytic leukemia: A systematic review and comparative epidemiological analysis.蒽环类药物-free 治疗在标准风险急性早幼粒细胞白血病中的优势:系统评价和比较流行病学分析。
Cancer Rep (Hoboken). 2024 Mar;7(3):e2035. doi: 10.1002/cnr2.2035.
6
Successfully treatment of PLZF-RARα positive acute promyelocytic leukemia by Venetoclax combining with decitabine: a case report and literature review.维奈托克联合地西他滨成功治疗 PLZF-RARα 阳性急性早幼粒细胞白血病:病例报告及文献复习。
Hematology. 2024 Dec;29(1):2399362. doi: 10.1080/16078454.2024.2399362. Epub 2024 Sep 15.
7
[The cure for acute promyelocytic leukemia and China's contributions].[急性早幼粒细胞白血病的治疗及中国的贡献]
Zhonghua Xue Ye Xue Za Zhi. 2025 May 14;46(5):377-384. doi: 10.3760/cma.j.cn121090-20250307-00119.
8
Long-term real-world outcomes of patients with acute promyelocytic leukaemia treated with arsenic trioxide and all-trans retinoic acid without chemotherapy-a retrospective, single-centre study.三氧化二砷联合全反式维甲酸无化疗治疗急性早幼粒细胞白血病患者的长期真实世界结局——一项回顾性单中心研究
Br J Haematol. 2023 Apr;201(2):249-255. doi: 10.1111/bjh.18618. Epub 2022 Dec 18.
9
[Acute promyelocytic leukemia with disseminated intravascular coagulation: a case report and literature review].
Zhonghua Xue Ye Xue Za Zhi. 2024 Dec 30;45(S1):85-88. doi: 10.3760/cma.j.cn121090-20241130-00502.
10
Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia.急性和慢性白血病患者弥散性血管内凝血的治疗
Cochrane Database Syst Rev. 2015 Jun 24;2015(6):CD008562. doi: 10.1002/14651858.CD008562.pub3.

本文引用的文献

1
ISCN 2024 - An International System for Human Cytogenomic Nomenclature (2024).《国际人类细胞基因组命名系统(2024)》(ISCN 2024)
Cytogenet Genome Res. 2024;164(Suppl 1):1-224. doi: 10.1159/000538512. Epub 2024 Nov 20.
2
A complex t(15;22;17)(q22;q11.2;q21) variant of APL.APL 中一种复杂的 t(15;22;17)(q22;q11.2;q21) 变体。
Cancer Genet. 2024 Aug;286-287:48-51. doi: 10.1016/j.cancergen.2024.07.003. Epub 2024 Jul 24.
3
A three‑way complex translocation of (15;15;17)(q24;q14;q21) involving two breakpoints on chromosome 15 in acute promyelocytic leukemia: A case report.
急性早幼粒细胞白血病中涉及15号染色体上两个断点的(15;15;17)(q24;q14;q21)三向复杂易位:一例报告。
Oncol Lett. 2023 Jun 2;26(1):309. doi: 10.3892/ol.2023.13895. eCollection 2023 Jul.
4
Epidemiology and early mortality patterns of acute promyelocytic leukemia in the United States.美国急性早幼粒细胞白血病的流行病学和早期死亡率模式。
Ann Hematol. 2023 May;102(5):1053-1062. doi: 10.1007/s00277-023-05154-0. Epub 2023 Mar 14.
5
The treatment of acute promyelocytic leukemia in 2023: Paradigm, advances, and future directions.2023年急性早幼粒细胞白血病的治疗:模式、进展与未来方向。
Front Oncol. 2023 Jan 18;12:1062524. doi: 10.3389/fonc.2022.1062524. eCollection 2022.
6
Atypical Rearrangements in APL-Like Acute Myeloid Leukemias: Molecular Characterization and Prognosis.APL样急性髓系白血病中的非典型重排:分子特征与预后
Front Oncol. 2022 Apr 12;12:871590. doi: 10.3389/fonc.2022.871590. eCollection 2022.
7
A novel fusion protein TBLR1-RARα acts as an oncogene to induce murine promyelocytic leukemia: identification and treatment strategies.一种新型融合蛋白 TBLR1-RARα 作为癌基因诱导小鼠早幼粒细胞白血病:鉴定和治疗策略。
Cell Death Dis. 2021 Jun 11;12(6):607. doi: 10.1038/s41419-021-03889-0.
8
Current views on the genetic landscape and management of variant acute promyelocytic leukemia.关于变异型急性早幼粒细胞白血病的遗传格局与管理的当前观点。
Biomark Res. 2021 May 6;9(1):33. doi: 10.1186/s40364-021-00284-x.
9
Cryptic t(15;17) acute promyelocytic leukemia with a karyotype of add(11)(p15) and t(13,20)- A case report with a literature review.隐匿性 t(15;17)急性早幼粒细胞白血病伴附加异常 11(p15)和 t(13,20)——附文献复习的 1 例报告
Bosn J Basic Med Sci. 2021 Apr 1;21(2):246-251. doi: 10.17305/bjbms.2020.5106.
10
Acute promyelocytic leukemia (APL): a review of the literature.急性早幼粒细胞白血病(APL):文献综述
Oncotarget. 2020 Mar 17;11(11):992-1003. doi: 10.18632/oncotarget.27513.